Funding opportunities

i4i FAST (Funding At the Speed of Translation) Awards Pilot Scheme

Deadline: None specified (the call can close at any time subject to budget and evaluation requirements)
Funding: Up to £50k per project

The brand new i4i FAST (Funding At the Speed of Translation) funding scheme is inviting innovators to submit applications that will answer a specific question, fund a single piece of activity or fill a specific evidence gap across all technology readiness levels. This could provide pivotal support by allowing innovations to be de-risked, further explored to justify further research and investment or to fail fast if simply not viable. Research themes can address any area of existing or emerging clinical unmet need.

This is the first round of i4i FAST Awards and will initially run as a pilot scheme. The Awards provide between £15k to £50k of funding for projects that can last between 3 to 6 months. FAST Awards are designed to have a rapid turnaround, and decisions to fund will be made within 6 to 8 weeks.

i4i FAST is a rolling call and there is no submission deadline. Applications can be submitted from 13:00 on 04 April 2022. The call can close at any time subject to budget and evaluation requirements.

i4i Challenge Awards

Deadline: Thursday 2nd June, 2022
Funding: Discretionary

The Challenge Awards will fund investigations of MedTech innovations in healthcare settings. The lead applicant or one of the co-applicants must be from an NHS Trust or NHS Service Provider. The aim is to shorten the evidence gap between the safety/efficacy typical of a newly or nearly CE-marked technology and what is required for decisions by commissioners and regulators. At the same time, this will de-risk the product for follow-on investment. Please note that nearly CE-marked technologies refers to technologies that are currently under Notified Body assessment, whereby all of the mandatory testing has been completed.

Surveillance and diagnostics for antimicrobial resistance

Deadline: Tuesday 14th June, 2022
Funding: Total fund : €1,000,000

Apply for MRC funding (partnership with JPIAMR) to develop networks to improve diagnostic and surveillance tools for antimicrobial resistance. Your networks must include experts and stakeholders. The full cost of your project can be up to €50,000. MRC will fund 80% of the cost and your project can run from 12 to 24 months. You should be based at a research organisation eligible for MRC funding and apply as part of a consortium of transnational partners.

Research for Patient Benefit – Competition 48

Deadline: Wednesday 13th July, 2022
Funding: Discretionary

The NIHR Research for Patient Benefit (RfPB) programme is inviting stage 1 applications for research proposals that are concerned with the day-to-day practice of health service staff, and that have the potential to have an impact on the health or wellbeing of patients and users of the NHS. As a researcher-led programme, RfPB does not specify topics for research but instead encourages proposals for projects that address a wide range of health service issues and challenges. The programme aims to fund high quality quantitative and qualitative research with a clear trajectory to patient benefit. It particularly encourages applications that have a strong element of interaction with patients and the public and that have been conceived in association with a relevant group of service users.

Highlight notices and themed calls

Research for Patient Benefit is currently participating in the following highlight notices and themed calls:

NIHR NICE Rolling Call (HSDR Programme) Stage 1

Deadline: Tuesday 19th July, 2022
Funding: Total Fund : Discretionary

The Health and Social Care Delivery Research (HSDR) Programme is accepting stage one applications to this funding opportunity. The programme is interested in receiving applications to meet recommendations in research identified in NICE guidance that has been published or updated since 2015. For the purposes of this call, NICE guidance includes the following:

  • clinical
  • social care
  • public health
  • technology appraisals
  • interventional procedures
  • diagnostics

Proposals must be within the remit of the HSDR Programme and the primary outcome measure must be health related. (This call is also open in the Public Health Research (PHR), Efficacy and Mechanism Evaluation (EME), and Health Technology Assessment (HTA) programmes for proposals which fall within the remit of those programmes – applicants should apply directly to the relevant programme).

Developmental pathway funding scheme

Deadline: Wednesday 20th July, 2022
Funding: Total Fund : £30,000,000

Apply for MRC’s funding to develop and test novel therapeutics, medical devices, diagnostics and other interventions. You must be based at a UK research organisation (includes NHS bodies) eligible for UKRI funding. Project should focus on at least one of the following stages of development:

  • early development and design
  • pre-clinical testing
  • early-phase clinical studies and trials (up to phase 2a).

There’s no limit on the amount of funding you can apply for, typically fund 80% of the full economic cost. This is an ongoing scheme with a budget of approximately £30 million a year. Application rounds open three times a year, in February, June and October.

Wellcome Discovery Awards

Deadline: Tuesday 26th July, 2022
Funding: Discretionary

This scheme provides funding for established researchers and teams from any discipline who want to pursue bold and creative research ideas to deliver significant shifts in understanding that could improve human life, health and wellbeing. A Wellcome Discovery Award provides funding for research expenses. You must aim to make a major contribution to your research field by generating significant shifts in understanding and/or developing methodologies, conceptual frameworks, tools or techniques that could benefit health-related research. Lead applicant can be a higher education institution, research institute, non-academic healthcare organisation or not-for-profit organisation.

Post-operative pain in patients undergoing spinal surgery

Deadline: Wednesday 27th July, 2022
Funding: Discretionary

The Health Technology Assessment Programme is accepting stage 1 applications to their commissioned workstream for this primary research topic. The HTA Programme wants to answer the question of the use of spinal block in patients undergoing spinal surgery. The Programme is aware that intrathecal diamorphine is beginning to enter wider use and therefore applicants are encouraged to consider addressing the use of intrathecal diamorphine within a three arm trial. Applications should be co-produced, demonstrating an equal partnership with service commissioners, providers and service users (or their advocates) in order to provide evidence and actionable findings of immediate utility to decision-makers and service users.

Pre-announcement: research in cognitive computational neuroscience

Deadline: Wednesday 27th July, 2022
Funding:  Upto £200,000 per project

Apply for funding to support interdisciplinary collaborations that integrate an understanding of neuroscience and cognition with artificial intelligence (AI). You must be eligible for UK Research and Innovation (UKRI) funding. Leadership must comprise expertise in both biological and computational disciplines. Projects can last up to 24 months and must begin no later than 15 February 2023. The full funding opportunity will open on 13 June 2022. Applicants from eligible UK-based organisations are invited, in accordance with standard UKRI practice.

Innovate UK Smart grants

Deadline: Wednesday 27th July, 2022
Funding:  Total fund of £25,000,000

UK registered organisations can apply for a share of up to £25 million for game-changing and commercially viable research and development (R&D) innovation that can significantly impact the UK economy. This funding is from Innovate UK, part of UK Research and Innovation. This competition is open to single applicants and collaborations. To lead a project your organisation must:

  • be a UK registered business
  • be a UK registered research and technology organisation
  • be or involve at least one micro, small or medium-sized enterprise
  • carry out all your R&D project activity in the UK
  • intend to commercially exploit the project results from the UK.

Application Development Award (ADA): Adult drug screening and brief interventions in key health, social care and justice settings

Deadline: Tuesday 16th August, 2022
Funding: Discretionary

The Public Health Research (PHR) Programme is accepting direct-to Stage 2 applications to this funding opportunity for scoping work to develop research proposals for evaluations of adult drug screening and brief and extended brief interventions in key health, social care and justice settings. Interested in receiving a one-stage proposal to (1) establish a research team with appropriate skills and expertise (2) to develop an application to complete a 2-phase evaluation (pilot and feasibility, followed by a trial/s) on the effectiveness and cost effectiveness of targeted drug screening and brief interventions (SBIs) including extended brief interventions in reducing drug use and associated harm in health, social care and justice settings in the UK, including a comparison of effectiveness between settings.

NIHR NICE Rolling Call (EME Programme)

Deadline: Tuesday 16th August, 2022
Funding: Discretionary

The Efficacy and Mechanism Evaluation Programme is accepting Stage 1 applications to this funding opportunity. The programme is interested in receiving applications to meet recommendations in research identified in NICE guidance that has been published or updated since 2015. For the purposes of this call, NICE guidance includes the following:

  • clinical
  • social care
  • public health
  • technology appraisals
  • interventional procedures
  • diagnostics

Proposals must be within the remit of the EME Programme and the primary outcome measure must be health related. (This call is also open in the Public Health Research (PHR), Health and Social Care Delivery Research (HSDR) and Health Technology Assessment (HTA) programmes for proposals which fall within the remit of those programmes – applicants should apply directly to the relevant programme).

Public Health Research Programme Rapid Funding Scheme

Deadline: Friday 29th December, 2023
Funding: Discretionary

The Rapid Funding Scheme (RFS) offers researchers the opportunity to apply for funds to conduct rapid baseline data collection, as well as other feasibility work, prior to intervention implementation, for unique, time limited opportunities such as a natural experiment or similar evaluations of a new public health intervention. This scheme is not intended to fund studies which provide definitive answers to questions to inform service provision – it is to prepare for such studies. The RFS has been set up to provide the public health research community with an accelerated route to funding for small-scale, short and time sensitive proposals that demonstrate a need for a rapid commissioning process to be followed. Funding will be offered, subject to appropriate scientific scrutiny, on the understanding that a full application to support completion of the evaluation will be forthcoming at an appropriate time point.

Global Innovation Fund

Deadline: None specified
Funding: Discretionary

The Global Innovation Fund is a non profit innovation fund headquartered in London with an office in Washington D.C. that invests in the development, rigorous testing, and scaling of innovations targeted at improving the lives of the world’s poorest people. Through our grants and risk capital, we help breakthrough solutions to global development challenges from for profit firms, non profit organisations, researchers, and government agencies to maximise their impact and affect meaningful change.

AUK-Asthma + Lung UK : Respiratory funding

Deadline: None specified
Funding: Project grants up to 300K

Respiratory funding call 2021 – Application deadline extended for project grants upto 3 years. Funding for a multi-year research project. Applications should focus on one or more of the disease areas in Chronic Obstructive Pulmonary Disease (COPD), Interstitial Lung Disease (ILDS), Pre-school wheeze.

NIHR: Health Technology Assessment

Deadline: None specified
Funding: Discretionary

The Health Technology Assessment (HTA) Programme funds research about the clinical and cost-effectiveness and broader impact of healthcare treatments and tests for those who plan, provide or receive care from NHS and social care services. They have a number of themed calls, please refer their website for more information.

NIHR: Efficacy and Mechanism Evaluation Programme

Deadline: None specified
Funding: Discretionary

The EME Programme primarily supports clinical trials, and other robustly designed studies that test the efficacy of interventions. The interventions should have the potential to improve patient care or benefit the public. The programme will only support studies where there is sufficient evidence that the intervention might work in man, i.e. that there is ‘proof of concept’. Current calls here include Cystic Fibrosis, Novel strategies to reduce overtreatment, Paediatric Care among others.

Horizon Europe

Deadline: None specified
Funding: €95.5 billion

Horizon Europe is an EU research and innovation programme. It has a budget of €95.5 billion and runs until 2027. If you’re a UK-based researcher or innovator, you can apply to most Horizon Europe funding opportunities on the same terms as EU-based applicants. Horizon Europe funding is available for excellent research in any field, researcher mobility, research infrastructure, global challenges and industrial competitiveness (health; culture, creativity and inclusive society; civil security for society; digital, industry and space; climate, energy and mobility; food, bioeconomy, natural resources, agriculture and environment), innovation, development of the European research and innovation systems. Details about the Horizon Europe programme structure can be found here.

EPSRC network grant

Deadline: None specified
Funding: Discretionary

Develop new interdisciplinary research communities and topics by supporting interaction between researchers and relevant science, technology and industrial groups. The aim is to transfer experimental techniques, models and scientific insights and promote mobility between academe, universities and industry. EPSRC prioritise interdisciplinary proposals and those that involve industrial or other users in any field of research relevant to our remit, particularly encourage involvement of small and medium-sized enterprises. Research area includes

  • Digital economy
  • Energy
  • Engineering
  • Global uncertainties
  • Healthcare technologies
  • Information and communication technologies
  • Living with environmental change
  • Manufacturing the future
  • Mathematical sciences
  • Physical sciences
  • Quantum technologies
  • Research infrastructure

EPSRC programme grant

Deadline: None specified
Funding: Discretionary

EPSRC programme grant provide flexible funding to world-leading UK research groups addressing significant research challenges and expect most successful proposals to be interdisciplinary and collaborative, but they can also address key challenges in a single discipline. Research area includes

  • Digital economy
  • Energy
  • Engineering
  • Healthcare technologies (also refer healthcare technologies investigator-led funding opportunity)
  • Information and communication technologies
  • Manufacturing the future
  • Mathematical sciences
  • Physical sciences
  • Quantum technologies
  • Global uncertainties
  • Living with environmental change
  • Research infrastructure

Programme grants are open to UK higher education institutions, research council institutes, UKRI-approved independent research organisations, public sector research establishments and NHS bodies with research capacity.

Nesta Impact Investment

Deadline: None specified
Funding: £1,000,000

Nesta Impact Investments is a £17.6m fund investing in life changing innovations that help tackle the major challenges faced by older people, children and communities in the UK.

New Horizons Grants – Cardiovascular research

Deadline: None specified
Funding: Up to £300,000 per project

Funding from BHF to encourage scientists from outside traditional cardiovascular biology to engage in cardiovascular research and bring novel expertise to the field to develop new technologies, models or methodologies and explore novel concepts. The principal investigator will be a senior researcher working in an established research institution in the UK. Early-stage concept development and testing, which may later lead to translational research, is appropriate for the New Horizons scheme. The proposed research plan should contain elements of developing novel technologies, models, applications or methodologies utilising the multidisciplinary background of the applicants.

Digital Health.London’s Accelerator programme

Deadline: None specified
Funding: Discretionary

DigitalHealth.London’s Accelerator programme aims to speed up the adoption of technology in London’s NHS, relieving high pressure on services and empowering patients to manage their health.

Companies successful in gaining a place on the programme usually have a product or service that has already been piloted in the NHS and is ready to scale.

Innovate UK Scale Up programme

Deadline: None specified
Funding: Not specified

Innovate UK EDGE’s highly regarded Scaleup Programme provides oneto-one, bespoke and fully funded support centered around innovative scaleups’ specific needs. It is available to those companies achieving, or with the potential for, 50% compound annual growth rates (CAGR) and over. The Scaleup Programme helps the highest potential businesses realise their ambitions. Delivering growth at scale is at the heart of Innovate UK’s emerging strategy for business innovation in the UK. Innovate UK EDGE is a key enabler of this strategic priority and through the Scaleup Programme, helps the highest potential businesses realise their ambitions.

The British Heart Foundation (BHF)

Deadline: None specified
Funding: Not available

BHF provide personal support for clinical and non-clinical cardiovascular researchers at all stages of their career. They also provide grants for short and long term research projects, essential infrastructure and strategic initiatives.

Pre-announcement: Public Health Intervention Development (PHIND): Sep 2022

Deadline: To be confirmed
Funding: £150,000

Apply for funding for the early-stage development of an intervention that seeks to address a UK or global public health challenge. The following activities are not within the scope of this opportunity:

  • NHS interventions
  • interventions treating clinical conditions or improving health services delivery
  • systematic reviews and meta-analyses
  • standalone feasibility studies and pilot studies
  • the wholesale transfer of a proven intervention to a new context, setting or target population.

Any researcher employed by an eligible research organisation, including MRC institutes and units (including those in Gambia and Uganda), can apply for this funding opportunity. The full economic cost of your project can be up to £187,500. MRC will typically fund 80% of the full economic cost. Your project can last up to 18 months.

Stay in Touch

Keep up to date with all HTE news and events.

  • Should be Empty: